PROCEDURAL AND IN-HOSPITAL OUTCOMES FOR PERCUTANEOUS BALLOON AORTIC VALVULOPLASTY IN PATIENTS WITH SEVERE CALCIFIC AORTIC STENOSIS AND LEFT VENTRICULAR END-DIASTOLIC DIAMETER <4.0 CM  by Gupta, Pritha P. et al.
E1334
JACC April 5, 2011
Volume 57, Issue 14
  VALVULAR HEART DISEASE
PROCEDURAL AND IN-HOSPITAL OUTCOMES FOR PERCUTANEOUS BALLOON AORTIC VALVULOPLASTY 
IN PATIENTS WITH SEVERE CALCIFIC AORTIC STENOSIS AND LEFT VENTRICULAR END-DIASTOLIC 
DIAMETER <4.0 CM
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Sunday, April 03, 2011, 3:30 p.m.-4:45 p.m.
Session Title: Aortic Valve Disease and its Treatment
Abstract Category: 19. Valvular Disease
Session-Poster Board Number:  1049-58
Authors: Pritha P. Gupta, Creighton W. Don, Manoj Kesarwani, Christian Witzke, Roberto J. Cubeddu, Jesus Herrero-Garibi, Eugene Pomerantsev, Angel 
E. Caldera, David McCarty, Ignacio Inglessis, Igor F. Palacios, The University of Washington, Seattle, WA, Seattle, WA
Background:  Percutaneous balloon aortic valvuloplasty (PBAV) is used for palliation, a bridge to surgery, and as an integral step in percutaneous 
aortic valve replacement. Similar to patients with worsened right ventricular outflow tract obstruction following pulmonic valvuloplasty, patients with 
small, thickened ventricles anecdotally are thought to have more complications during and following PBAV. We evaluate the impact of left ventricular 
(LV) chamber size on procedural and hospital outcomes of patients undergoing PBAV.
Methods:  This was a retrospective study of patients with severe, symptomatic calcific aortic stenosis who underwent retrograde PBAV at 
Massachusetts General Hospital from 2004-2008. We compared patients in the lowest quartile in terms of left ventricular end-diastolic dimension 
(LVEDD <4.0 cm), to those in the middle and upper quartiles (LVEDD ≥4.0 cm). Baseline and procedural characteristics as well as clinical outcomes 
were compared. Multivariate logistic regression was used for the adjusted analysis.
Results:  There were 109 patients who underwent PBAV, 31 of whom had LVEDD <4.0 cm and 78 who had LVEDD >4.0 cm. Patients with small 
LV chamber size were mostly women (80.7% vs. 19.4%, p <0.01) and had a smaller body surface area (BSA) (1.61 ± 0.20 m2 vs. 1.79 ± 0.25 m2, 
p < 0.00). Pre-procedure, patients with small LV chamber size had higher ejection fractions (65.2% vs. 46.5%, p <0.01) but lower cardiac output 
measurements. Otherwise, baseline characteristics were similar. Patients with smaller LV chambers were more likely to need vasopressors (12.5% vs. 
4.1%, p <0.01), have tamponade (6.5% v. 0.0%, p = 0.02) and experience the composite of these outcomes as well as death, myocardial infarction 
and cardiopulmonary arrest (38.7% v. 19.5% p = 0.04). Adjusting for age, gender, BSA and NYHA class, LVEDD <4.0 cm remained an independent 
predictor of the composite outcome of these complications (odds ratio 3.6, 95% confidence interval 1.2-10.7). Age, gender and BSA were not 
associated with worse outcomes in the unadjusted or adjusted analyses.
Conclusions:  Compared to patients with LVEDD ≥4.0 cm, those with small LV chambers had worse procedural and in-hospital clinical outcomes.
